Editorial Comment to Utility of whole‐body diffusion‐weighted magnetic resonance imaging in the management of treatment‐related neuroendocrine prostate cancer
Main Authors: | Soichiro Yoshida, Yasuhisa Fujii |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-03-01
|
Series: | IJU Case Reports |
Online Access: | https://doi.org/10.1002/iju5.12248 |
Similar Items
-
Utility of whole‐body diffusion‐weighted magnetic resonance imaging in the management of treatment‐related neuroendocrine prostate cancer
by: Ryo Kurashina, et al.
Published: (2021-03-01) -
Whole-body diffusion-weighted magnetic resonance imaging by estimating the measurable diffusion coefficient in Hodgkin lymphoma
by: A. I. Mikhaylov, et al.
Published: (2016-02-01) -
Magnetic resonance diffusion-weighted whole-body imaging (DWIBS) in bladder cancer diagnostics
by: Ponukalin A.N., et al.
Published: (2011-12-01) -
Magnetic resonance diffusion-weighted whole-body imaging (DWIBS) in the urinary bladder cancer diagnostics
by: Viktor V. Zuev, et al.
Published: (2012-09-01) -
Whole-body MRI including diffusion-weighted MRI compared with 5-HTP PET/CT in the detection of neuroendocrine tumors
by: Lina Carlbom, et al.
Published: (2017-01-01)